Infliximab and Adalimumab Drug Levels in Crohn's Disease: Contrasting Associations With Disease Activity and Influencing Factors
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14124
Full Text
Open PDFAbstract
Available in full text
Date
May 8, 2017
Authors
Publisher
Wiley